RNA interference: potential therapeutic targets

@article{Jana2004RNAIP,
  title={RNA interference: potential therapeutic targets},
  author={Snehasis Jana and Chaitaly T. Chakraborty and Shivani Nandi and J. K. Deb},
  journal={Applied Microbiology and Biotechnology},
  year={2004},
  volume={65},
  pages={649-657}
}
One of the most exciting findings in recent years has been the discovery of RNA interference (RNAi). RNAi methodologies hold the promise to selectively inhibit gene expression in mammals. RNAi is an innate cellular process activated when a double-stranded RNA (dsRNA) molecule of greater than 19 duplex nucleotides enters the cell, causing the degradation of not only the invading dsRNA molecule, but also single-stranded (ssRNAs) RNAs of identical sequences, including endogenous mRNAs. The use of… 
Illuminating the Gateway of Gene Silencing: Perspective of RNA Interference Technology in Clinical Therapeutics
TLDR
The recent discoveries associated with the phenomenon of RNAi, expression of silencing molecules in mammals along with the vector systems used for disease therapeutics are highlighted.
In vivo delivery aspects of miRNA, shRNA and siRNA.
TLDR
The types of RNAi and their application in a variety of diseases using both local and systemic delivery approaches are described and it is sure that advancement in this direction will evolve a new landscape for treating a range of diseases.
Nonviral methods for siRNA delivery.
TLDR
This review provides an overview of the current delivery strategies for synthetic siRNA, focusing on the targeted, self-assembled nanoparticles which show potential to become a useful and efficient tool in cancer therapy.
Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2
The sense strand pre-cleaved RNA duplex mediates an efficient RNA interference with less off-target and immune response effects
TLDR
It is reported that RNA duplex with the sense strand pre-cleaved at the base between base 10 and 11 relative to the 5′ end of the antisense strand induced a target-specific RNA silencing effectively.
BARRIERS TO SUCCESSFUL DELIVERY OF SHORT INTERFERING RNA AFTER SYSTEMIC ADMINISTRATION
  • P. White
  • Biology
    Clinical and experimental pharmacology & physiology
  • 2008
TLDR
The present review considers the biological barriers that limit the movement of siRNA from vascular lumen to target cell cytoplasm and the strategies that have been used to overcome them.
Off-target possibility of efficient siRNA using String matching
  • S. Prameela, A. S. Jereesh
  • Biology
    2017 International Conference on Circuit ,Power and Computing Technologies (ICCPCT)
  • 2017
TLDR
This work uses string matching algorithm in GPU instead of BLAST to design an efficient exogenous siRNA and the original experimental value of Huesken data set is used to evaluate the current work.
Cationic lipids and polymers mediated vectors for delivery of siRNA.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 95 REFERENCES
RNAi: gene-silencing in therapeutic intervention.
Interfering with disease: opportunities and roadblocks to harnessing RNA interference
RNA interference in functional genomics and medicine.
  • V. Kim
  • Biology
    Journal of Korean medical science
  • 2003
TLDR
RNA interference is the sequence-specific gene silencing induced by double-stranded RNA (dsRNA) that provides a powerful tool for functional genomics but also holds a promise for gene therapy.
siRNA technology
  • N. Schütze
  • Biology
    Molecular and Cellular Endocrinology
  • 2004
Therapeutic gene silencing in the nervous system.
TLDR
The challenges ahead will be to identify appropriate disease gene targets and, crucially, to understand the biological parameters that determine safe, precise and effective delivery and function of RNA-based therapeutic molecules within the unique environment of the nervous system.
Control of HIV-1 replication by RNA interference.
Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells
TLDR
A mammalian Pol III promoter system is described capable of expressing functional double-stranded siRNAs following transfection into human cells and achieving up to 4 logs of inhibition of expression from the HIV-1 DNA.
The specifics of small interfering RNA specificity
  • A. Dillin
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2003
TLDR
Biochemical evidence indicates the siRNAs are incorporated into a multisubunit protein complex, the RNAi-induced silencing complex (RISC), which directs the siRNA to the appropriate mRNA.
RNAi functions in cultured mammalian neurons
TLDR
An application of RNAi to postmitotic primary neuronal cultures is reported, which shows that synthetic siRNA can be readily introduced into neurons and effectively inhibit the expression of endogenous and transfected genes.
Modulation of HIV-1 replication by RNA interference
TLDR
The utility of RNAi for modulating the HIV replication cycle is demonstrated and evidence that genomic HIV-1 RNA, as it exists within a nucleoprotein reverse-transcription complex, is amenable to siRNA-mediated degradation is provided.
...
1
2
3
4
5
...